Details for New Drug Application (NDA): 214180
✉ Email this page to a colleague
The generic ingredient in DEFERASIROX is deferasirox. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the deferasirox profile page.
Summary for 214180
Tradename: | DEFERASIROX |
Applicant: | Teva Pharms Usa |
Ingredient: | deferasirox |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 214180
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DEFERASIROX | deferasirox | GRANULE;ORAL | 214180 | ANDA | Actavis Pharma, Inc. | 0591-4730 | 0591-4730-30 | 30 PACKET in 1 CARTON (0591-4730-30) / 1 GRANULE in 1 PACKET (0591-4730-54) |
DEFERASIROX | deferasirox | GRANULE;ORAL | 214180 | ANDA | Actavis Pharma, Inc. | 0591-4735 | 0591-4735-30 | 30 PACKET in 1 CARTON (0591-4735-30) / 1 GRANULE in 1 PACKET (0591-4735-54) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | 90MG | ||||
Approval Date: | Nov 19, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | 180MG | ||||
Approval Date: | Nov 19, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | 360MG | ||||
Approval Date: | Nov 19, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription